Interim Stage 2 Analysis Confirms Hyperacute and Acute Ischaemic Stroke Detection Capabilities
Stage 2 data confirms positive AI algorithm performance to help answer the “clot or not” question. This comes off the back of earlier positive news of the AI detecting "blood or not".
![c0358d2d8bf863759c33c09d6e71150615b1b5.png](//strawman.com/member/uploads/objects/30/c0358d2d8bf863759c33c09d6e71150615b1b5.png)
Key clinical question of “ischaemia or not” (“clot or not”) - current non-contrast computed tomography NCCT scans shows a limited sensitivity to detecting acute ischaemia
Other tests are required for patients with suspected ischemic stroke to confirm diagnosis - advanced imaging modalities such as CT Angiogram, CT Perfusion or MRI are often used to confirm the presence of ischaemia (‘clot or not’) and determine a patient’s eligibility for thrombectomy (clot retrieval).
Depending on the neuro-diagnosis, and treatment capabilities of the hospital to perform urgent intervention, a time critical decision is whether to transfer the patient to a comprehensive stroke centre, or not.
Continues the good progress and news on Stage 2 Trials.
Discl: Held IRL and SM